Association of serum NOD-like receptor protein 3 levels with impaired fat tolerance and hypertriglyceridemia-Reference-Cited by-同舟云学术

Association of serum NOD-like receptor protein 3 levels with impaired fat tolerance and hypertriglyceridemia

Published:2023 Issue:5 Volume:70 Page:529-539
ISSN:0918-8959
Container-title:Endocrine Journal
language:en
Short-container-title:Endocr J

Author:

Zheng Kunjie¹,Li Xiaolong²,Hou Liping²,Gu Wei¹,Hou Xiaoyu¹,Wang Chao³,Song Guangyao¹

Affiliation:

1. Department of Internal Medicine, Hebei Medical University, Shijizhuang, Hebei 050017, China

2. Department of Endocrinology, Harrison International Peace Hospital, Hengshui, Hebei 053000, China

3. Hebei Key Laboratory of Metabolic Diseases, Hebei General Hospital, Shijiazhuang, Hebei 050051, China

Publisher

Japan Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.jstage.jst.go.jp/article/endocrj/70/5/70_EJ22-0563/_pdf

Reference42 articles.

1. 1 Li JH, Wang LM, Li YC, Bi YF, Jiang Y, et al. (2012) Prevalence of dyslipidemia in Chinese adults in 2010. Zhonghua Yu Fang Yi Xue Za Zhi 46: 414–418 (In Chinese).

2. 2 Pan L, Yang Z, Wu Y, Yin RX, Liao Y, et al. (2016) The prevalence, awareness, treatment and control of dyslipidemia among adults in China. Atherosclerosis 248: 2–9.

3. 3 Patel A, Barzi F, Jamrozik K, Lam TH, Ueshima H, et al. (2004) Serum triglycerides as a risk factor for cardiovascular diseases in the Asia-Pacific region. Circulation 110: 2678–2686.

4. 4 Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A (2007) Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 298: 299–308.

5. 5 Freiberg JJ, Tybjaerg-Hansen A, Jensen JS, Nordestgaard BG (2008) Nonfasting triglycerides and risk of ischemic stroke in the general population. JAMA 300: 2142–2152.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum Gamma Glutamyltransferase: A Biomarker for Identifying Postprandial Hypertriglyceridemia;Diabetes, Metabolic Syndrome and Obesity;2024-06